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Background: Toll-like receptors (TLRs) are evolutionarily conserved pattern recognition receptors that mediate host
responses to pathogens. To date, at least 10 different TLRs have been identified in chickens including TLR2, which
binds lipopeptides and other similar ligands such as Pam3CSK4, TLR3, which binds double stranded RNA as well as
synthetic molecules such as poly I:C, TLR4, which binds lipopolysaccharide (LPS), and TLR21, which binds CpG DNA
motifs. In mammals, TLRs have been detected on CD4+ T cells where they mediate cellular survival, proliferation
and the production of cytokines. However, the TLR-mediated responses in chicken CD4+ T cells remain to be
determined. As such, the objective of the present study was to elucidate the kinetics of cytokine response to
several different TLR ligands in chicken CD4+ T cells.
Results: The results suggest that these cells express TLRs 2, 3, 4 and 21 at the transcript level, and treatment with
ligands for these TLRs significantly influenced the expression of the cytokines interferon (IFN)-γ and interleukin
(IL)-17, but not IL-4, IL-10 and IL-13. Specifically, treatment with Pam3CSK4, poly I:C and LPS up-regulated IFN-γ
transcripts, while CpG ODN significantly down-regulated them. In contrast, at least one dose of each of the TLR
ligands, except for Pam3CSK4, significantly down-regulated IL-17 transcripts.
Conclusion: Chicken CD4+ T cells respond to ligands for TLRs 2, 3, 4 and 21 by up-regulating or down-regulating
cytokine transcripts. Future studies may consider exploring how these TLR ligands may modulate other effector
functions in chicken CD4+ T cells, as well as in other T cell subsets such as CD8+ T cells.
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CpGBackground
Toll-like receptors (TLRs) are evolutionarily conserved
pattern recognition receptors that bind conserved motifs
on pathogens termed pathogen associated molecular
patterns (PAMPs) [1]. To date, at least 10 different TLRs
have been identified in chickens including TLR2, which
binds lipopeptides (e.g. Pam3CSK4) and other similar
ligands, TLR3, which binds double stranded RNA (e.g.
poly I:C), TLR4, which binds lipopolysaccharide (LPS),
and TLR21, which binds CpG DNA motifs [2]. Toll-like
receptors have been detected in several cell subsets in-
cluding in macrophages, heterophils and B cells [3].* Correspondence: shayan@uoguelph.ca
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reproduction in any medium, provided the orInteractions between TLRs and their ligands typically
results in cellular activation, enhanced effector functions
and the production of cytokines. In the case of mamma-
lian T cells, TLR stimulation promotes cell proliferation
and survival as well as induction of cytokines, such as
interferon (IFN)-γ [4-7]. In addition, TLR stimulation
may also promote the differentiation of naïve CD4+ T
cells into one of the many different T-helper (TH) cell
subsets [8]. To date, several different TLRs have been
detected in mammalian CD4+ T cells [9].
Although well documented in mammals, the TLR-
mediated responses in chicken T cells have yet to be eluci-
dated. So far, a few TLRs have been identified in chicken
CD4+ T cells including TLRs 2, 3 and 4 [3]. However, the
full repertoire of TLRs expressed in chicken CD4+ T cells
and their responses to TLR ligands have yet to beLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cells express TLRs and respond to TLR ligands by up-
regulating cytokine transcripts. As such, the objective of
the present study was to examine the kinetics of the TLR-
mediated cytokine response in chicken CD4+ T cells. The
results suggest that CD4+ T cells express TLRs 2, 3, 4 and
21 at the transcript level, and treatment with ligands for
these TLRs significantly influenced the expression of the
cytokines IFN-γ and interleukin (IL)-17, but not IL-4, IL-
10 and IL-13.
Results and discussion
Toll-like receptor ligands have previously been shown to
modulate the production of cytokines in several chicken
cell subsets, including in macrophages, heterophils and
B cells [10-12]. Here, we show that a similar
phenomenon may be extended to chicken CD4+ T cells.
In mammals, CD4+ T cells may be classified into several
different subsets such as TH1, TH2, TH17 and regulatory
T cells (TREG) [13]. In addition to producing a distinct
profile of cytokines and performing different effector
functions, each cell subset also expresses a different rep-
ertoire of TLRs. For example, TLR10 has been detected
in human regulatory T cells, but not in non-regulatory
CD4+ T cells [14]. Nevertheless, CD4+ T cells, in general,
express transcripts for TLRs 2, 3, 4, 5, 7/8 and 9 in both
mice and humans [9]. In chicken CD4+ T cells, it was
shown that they also express TLRs transcripts including
those for TLRs 2, 3 and 4 [3]. However, the study by
Iqbal et al., (2005) used semi-quantitative PCR and as
such, we employed real-time PCR to provide a more ac-
curate quantification of TLR transcript levels (Figure 1).
Our results suggest chicken CD4+ T cells express TLRs
2, 3, 4 and 21 at the transcript level, and not TLRs 5
and 7. Moreover, transcripts for TLR2 were the most
abundant, followed by transcripts for TLR3 and lastly
by TLRs 4 and 21. This therefore raises the possibility
that chicken CD4+ T cells may have the potential toFigure 1 TLR expression in chicken CD4+ T cells. Gene
expression of TLR transcripts in un-stimulated chicken CD4+ T cells
relative to the house-keeping gene β-actin.respond directly to PAMPs derived from both viral and
bacterial pathogens.
Different mammalian CD4+ cell subsets produce a
distinct profile of cytokines upon stimulation. These
cytokines include IFN-γ, which is produced by TH1 cells
and IL-4/13 which are produced by TH2 cells, as well as
IL-17 and IL-10, which are produced by TH17 cells and
TREGS, respectively. Although in chickens it is not yet
known if such CD4+ T cell subsets exist, evidence accu-
mulated over the last few years raises the possibility that
at least some of these subsets might [15-17]. As such, in
the present study, we examined the above cytokines to
determine how TLR ligands modulate their expression
(Figures 2 and 3).
In mammals, TLR2 ligands such as Pam3CSK4 have
been shown to directly activate CD4+ T cells and induce
their production of IFN-γ, in the absence of T cell recep-
tor (TCR) signaling [5,7]. Our results suggest that this
may also be the case in chicken CD4+ T cells, as treat-
ment with Pam3CSK4 significantly up-regulated IFN-γ
transcripts at 3 (p ≤0.01) and 8 (p ≤0.01) hours post-
treatment (Figure 2). This effect was not limited only to
Pam3CSK4, as both poly I:C (p ≤0.01) and LPS (p ≤0.05)
significantly enhanced IFN-γ transcripts levels as well
(Figure 2). This is in contrast to what occurs in mam-
mals, as poly I:C and LPS fail to directly up-regulate
IFN-γ production in TH1 cells [7]. In fact, when com-
bined with TCR stimulation, LPS inhibits IFN-γ produc-
tion in mammalian T cells, which was shown to be
mediated by the TIR-domain-containing adapter-
inducing interferon-β (TRIF) pathway [18]. In chickens,
emerging evidence suggests that both TLRs 3 and 4 sig-
nal through the TRIF pathway as indicated by a robust
type I IFN response following treatment with these
ligands [19-21]. However, as these ligands both up-
regulated IFN-γ transcripts in the present study, this
raises the possibility that there might be some differ-
ences between the chicken and mammalian TRIF path-
ways, potentially with respect to the accessory and
signaling molecules involved. As such, future studies
should be aimed at further elucidating the mechanisms
involved in the TRIF signaling pathway in chickens.
We discovered that there was a significant down-
regulation (controls were set to 1) of IFN-γ transcripts
following treatment CpG ODN at 1 (p ≤0.01) and 8
(p ≤0.05) hours post-treatment (Figure 2). This is in con-
trast with what has been shown in mammalian CD4+
T cells, because CpG ODN enhances production of cyto-
kines such as IL-2 and IFN-γ by these cells [22]. How-
ever, this enhanced cytokine production occurs only in
conjunction with TCR signaling, and as such, future
studies may consider exploring whether adding anti-
chicken CD3 may alter the responses to CpG ODN and
other TLR ligands.
Figure 2 Gene expression of IFN-γ. Relative gene expression of IFN-γ in chicken CD4+ T cells at 1, 3, 8 and 18 hours post-treatment with low
(1 μg/mL) and high (5 μg/mL) doses of the TLR ligands Pam3CSK4, LPS and CpG ODN, or with a low (10 μg/mL) or high (50 μg/mL) dose of
poly I: C. Graphed data represent mean fold change of 4 treatment replicates compared to the medium control group ± standard error. Results
were considered statistically significant from the medium-treated control group if p ≤ 0.05 (*) and p ≤ 0.01 (**).
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ligands may also modulate responses of other T cell
subsets, such as TH17 cells. For example, treatment of
naïve CD4+ T cells with Pam3CSK4 promotes their
differentiation into TH17 cells [8]. Importantly, when
fully differentiated TH17 cells are treated with TLR
ligands including Pam3CSK4 and LPS, but not poly I:C, a
significant increase in IL-17 production is observed [8].
However, this does not appear to be the case in chickens,
as suggested by our results (Figure 3). We found that
both poly I:C, and the high dose of CpG ODN (p ≤0.01)
significantly down-regulated IL-17 transcripts at 1 hour
and 8 hours post-treatment, respectively. Moreover, we
found that treatment with the low dose of LPS signifi-
cantly down-regulated IL-17 transcripts at 1 hour post-
treatment (p ≤0.01), while the high dose significantlyFigure 3 Gene expression of IL-17. Relative gene expression of IL-17 in c
(1 μg/mL) and high (5 μg/mL) doses of the TLR ligands Pam3CSK4, LPS an
I:C. Graphed data represent mean fold change of 4 treatment replicates co
considered statistically significant from the medium-treated control groupup-regulated IL-17 at 1 hour post-treatment (p ≤0.05).
Although the reason behind this observation is not
known, we have observed a similar down-regulation of
murine natural killer T (NKT) cell activities in response
to some TLR ligands, including CpG ODN, which we
have attributed to a TLR-mediated increase in dual spe-
cific protein phosphatases (DUSPs) (Villanueva et al.,
unpublished data). As such, future studies may con-
sider employing additional assays in order to exam-
ine the role of DUSPs in chicken TLR mediated
responses.
In mammals, evidence suggests that TH2 cells are
non-responsive to TLR ligands and fail to become acti-
vated and up-regulate the production of IL-4 [7]. This
seems to also be the case in chickens, as we did not
detect any significant up-regulation of IL-4 or IL-13 inhicken CD4+ T cells at 1, 3, 8 and 18 hours post-treatment with low
d CpG ODN, or with a low (10 μg/mL) or high (50 μg/mL) dose of poly
mpared to the medium control group ± standard error. Results were
if p ≤ 0.05 (*) and p ≤ 0.01 (**).
Table 1 Primer sequences and accession numbers used for real-time PCR
Target gene Primer sequence Accession number
TLR2 F: 5’- ATCCTGCTGGAGCCCATTCAGAG -3’ [GenBank: NM_204278.1/NM_001161650]
R: 5’- TTGCTCTTCATCAGGAGGCCACTC -3’
TLR3 F: 5’- TCAGTACATTTGTAACACCCCGCC -3’ [GenBank: DQ780341]
R: 5’- GGCGTCATAATCAAACACTCC -3’
TLR4 F: 5’- TGCCATCCCAACCCAACCACAG -3’ [GenBank: AY064697.1]
R: 5’- ACACCCACTGAGCAGCACCAA -3’
TLR5 F: 5’- TTCTTGCAACCTCACAGGTGTTCC -3’ [GenBank: NM_001024586.1]
R: 5’- CAGGTCCAAGACACGAAGATT -3’
TLR7 F: 5’- TTCTGGCCACAGATGTGACC -3’ [GenBank: NM_001011688]
R: 5’- CCTTCAACTTGGCAGTGCAG -3’
TLR21 F: 5’- CCTGCGCAAGTGTCCGCTCA -3’ [GenBank: AJ720600.1]
R: 5’- GCCCCAGGTCCAGGAAGCAG -3’
IFN-γ F: 5’- ACACTGACAAGTCAAAGCCGCACA-3’ [GenBank: X99774]
R: 5’-AGTCGTTCATCGGGAGCTTGGC-3’
IL-4 F: 5’-TGTGCCCACGCTGTGCTTACA-3’ [GenBank: AJ621249.1]
R: 5’- CTTGTGGCAGTGCTGGCTCTCC-3’
IL-10 F: 5’- AGCAGATCAAGGAGACGTTC −3’ [GenBank: AJ621614]
R: 5’- ATCAGCAGGTACTCCTCGAT −3
IL-13 F: 5’- ACTTGTCCAAGCTGAAGCTGTC -3’ [GenBank: AJ621250]
R: 5’- TCTTGCAGTCGGTCATGTTGTC -3’
IL-17 F: 5’- CACTGCTGTTGGTGTTGCT -3’ [GenBank: AJ493595]
R: 5’- TCAGCAACCAAGCGGGGG -3’
β-Actin F: 5’-CAACACAGTGCTGTCTGGTGGTA-3’ [GenBank: X00182]
R: 5’-ATCGTACTCCTGCTTGCTGATCC-3’
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not shown). In addition, we also did not detect any
significant up-regulation of IL-10 either in response to
Pam3CSK4 or any of the other TLR ligands (data not
shown). Although in mammals IL-10 may be produced
by TH2 cells as well as TREGS, in chickens, evidence
suggests that stimulated CD4+ CD25+ regulatory T
cells are the predominant source of IL-10, as they pro-
duce more than 30 times the amount of IL-10 when
compared against stimulated CD4+ CD25- T cells [15].
Nevertheless, TLR ligands have been shown to directly
activate mammalian TREGS and promote their prolifera-
tion and survival, however this occurred only in con-
junction with TCR stimulation [4]. Therefore, we
speculate that this lack of up-regulation in the chicken
CD4+ T cells may be due to lack of TCR stimulation.
However, there are a few other possible explanations
that could be considered. For example, i) chicken
TREGS may not respond to TLR ligands or ii) our T
cell population may potentially be limited in its diver-
sity and may have an oligoclonal or monoclonal na-
ture. As a result, the population of T cells that we
have used in the present study might have been devoid
of TH2 and TREG populations.Conclusions
In conclusion, we have shown that chicken CD4+ T cells
express several TLRs at the transcript level and respond
to treatment with TLR ligands by modulating the ex-
pression of IFN-γ and IL-17 transcripts, but not IL-4,
IL-10 or IL-13. Future studies may consider exploring
how these TLR ligands may modulate other effector
functions in chicken CD4+ T cells, as well as in other
T cell subsets such as CD8+ T cells.Methods
TLR ligands
Pam3CSK4 was purchased from Invivogen (Burlington,
ON), poly I:C and LPS from Escherichia coli 0111:B4
were purchased from Sigma-Aldrich-Canada (Oakville,
ON), while synthetic class B CpG ODN 2007 [5’- TC
GTCGTTGTCGTTTTGTCGTT-3’] and non-CpG ODN
[5’- TGCTGCTTGTGCTTTTGTGCTT-3’] were pur-
chased from Eurofins MWG Operon (Ebersberg, GER).
All of the ligands used were re-suspended in sterile
water or phosphate buffered saline (PBS, pH 7.4) and
diluted to working concentrations in complete RPMI
medium.
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Reticuloendotheliosis virus transformed CD4+ T cells
were generated using the protocol previously described
for transforming chicken B cells [23], with slight modifi-
cations. In the present study, mononuclear splenocytes
from 1 week-old chickens were used as the starting cell
population. After transformation, the cells were passaged
several times, leading to elimination of non-transformed
cells. Subsequently, purity of the transformed cells
was assessed using flow cytometry. T cells were then
cultured in RPMI-1640 (Invitrogen, Burlington, ON)
supplemented with 10% heat-inactivated fetal bovine
serum, 200 U/mL penicillin, 80 μg/mL streptomycin,
25 mg gentamicin, 10 mM HEPES buffer, 50 μM β-
mercaptoethanol, and 2 mM L-glutamine, and seeded
into 48-well plates at 1x107 cells/mL for in vitro stimula-
tion with either a low (1 μg/mL) or high (5 μg/mL) dose
of each TLR ligand, except for poly I:C, which was deliv-
ered at 10 μg/mL or 50 μg/mL, respectively. The control
groups received non-CpG ODN (5 μg/mL) or medium.
Cells were harvested at 1, 3, 8 and 18 hours post-
stimulation for RNA extraction.
RNA extraction and cDNA synthesis
Total RNA was extracted from T cells using TRIzolW
(Invitrogen, Carlsbad, CA) according to the manufac-
turer’s protocol and treated with DNA FreeW (Ambion,
Austin, TX) DNAse. Subsequently, 1μg of purified RNA
was reverse transcribed to cDNA using SuperscriptW II
First Strand Synthesis kit (Invitrogen, Carlsbad, CA) and
oligo-dT primers, according to the manufacturers
recommended protocol. The resulting cDNA was subse-
quently diluted 1:10 in DEPC treated water.
Real-time PCR
Quantitative real-time PCR using SYBR Green was per-
formed on diluted cDNA using the LightCyclerW 480 II
(Roche Diagnostics GmbH, Mannheim, GER) as previ-
ously described [19]. Briefly, each reaction involved a
pre-incubation at 95°C for 10 min, followed by 45 cycles
of 95°C for 10 min, 55°C −64°C (TA as per primer) for
5 s, and elongation at 72°C for 10 s. Subsequent melt
curve analysis was performed by heating to 95°C for 10 s,
cooling to 65°C for 1 min, and heating to 97°C. Primers
were synthesized by Sigma-Aldrich-Canada (Oakville,
ON), and their specific sequences and accession numbers
are outlined in Table 1.
Data analysis
Relative expression levels of all genes was calculated
relative to the housekeeping gene β-actin using the
LightCyclerW 480 Software (Roche Diagnostics GmbH,
Mannheim, GER), based on the formula developed by
Pfaffl [24]. Data represent mean fold change of 4replicates compared to the medium control group ±
standard error. The transcript levels in the medium-
treated control group were set to 1. Results were consid-
ered statistically significant from the medium-control
group if p ≤ 0.05 (*) and p ≤ 0.01 (**). Fold changes,
standard error and statistical significance were calcu-
lated using the software REST 2009 (Qiagen, Valencia,
CA) [25].
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